PDB Short entry for 3AMV HEADER TRANSFERASE 18-FEB-99 3AMV TITLE ALLOSTERIC INHIBITION OF GLYCOGEN PHOSPHORYLASE A BY A POTENTIAL TITLE 2 ANTIDIABETIC DRUG COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (GLYCOGEN PHOSPHORYLASE); COMPND 3 CHAIN: A; COMPND 4 EC: 2.4.1.1 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ORYCTOLAGUS CUNICULUS; SOURCE 3 ORGANISM_COMMON: RABBIT; SOURCE 4 ORGANISM_TAXID: 9986; SOURCE 5 TISSUE: MUSCLE KEYWDS DIABETES, GLYCOGEN METABOLISM, PHOSPHORYLASE A, INHIBITION, KEYWDS 2 ALLOSTERIC SITE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR N.G.OIKONOMAKOS,K.E.TSITSANOU,S.E.ZOGRAPHOS,V.T.SKAMNAKI REVDAT 6 29-JUL-20 3AMV 1 COMPND REMARK SEQADV HETNAM REVDAT 6 2 1 LINK SITE REVDAT 5 13-JUL-11 3AMV 1 VERSN REVDAT 4 24-FEB-09 3AMV 1 VERSN REVDAT 3 23-JUN-00 3AMV 1 REMARK DBREF HETNAM REVDAT 2 23-DEC-99 3AMV 1 JRNL HEADER REVDAT 1 26-FEB-99 3AMV 0 JRNL AUTH N.G.OIKONOMAKOS,K.E.TSITSANOU,S.E.ZOGRAPHOS,V.T.SKAMNAKI, JRNL AUTH 2 S.GOLDMANN,H.BISCHOFF JRNL TITL ALLOSTERIC INHIBITION OF GLYCOGEN PHOSPHORYLASE A BY THE JRNL TITL 2 POTENTIAL ANTIDIABETIC DRUG 3-ISOPROPYL JRNL TITL 3 4-(2-CHLOROPHENYL)-1,4-DIHYDRO-1-ETHYL-2-METHYL-PYRIDINE-3, JRNL TITL 4 5,6-TRICARBO XYLATE. JRNL REF PROTEIN SCI. V. 8 1930 1999 JRNL REFN ISSN 0961-8368 JRNL PMID 10548038 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH K.E.TSITSANOU,N.G.OIKONOMAKOS,S.E.ZOGRAPHOS,V.T.SKAMNAKI, REMARK 1 AUTH 2 M.GREGORIOU,K.A.WATSON,L.N.JOHNSON,G.W.J.FLEET REMARK 1 TITL EFFECTS OF COMMONLY USED CRYOPROTECTANTS ON GLYCOGEN REMARK 1 TITL 2 PHOSPHORYLASE ACTIVITY AND STRUCTURE REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 1 REFERENCE 2 REMARK 1 AUTH S.E.ZOGRAPHOS,N.G.OIKONOMAKOS,K.E.TSITSANOU,D.D.LEONIDAS, REMARK 1 AUTH 2 E.D.CHRYSINA,V.T.SKAMNAKI,H.BISCHOFF,S.GOLDMAN,M.SCHRAMM, REMARK 1 AUTH 3 K.A.WATSON,L.N.JOHNSON REMARK 1 TITL THE STRUCTURE OF GLYCOGEN PHOSPHORYLASE B WITH AN REMARK 1 TITL 2 ALKYL-DIHYDROPYRIDINE- DICARBOXYLIC ACID COMPOUND, A NOVEL REMARK 1 TITL 3 AND POTENT INHIBITOR REMARK 1 REF STRUCTURE V. 5 1413 1997 REMARK 1 REFN ISSN 0969-2126 REMARK 1 DOI 10.1016/S0969-2126(97)00292-X REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.8 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 13.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.9 REMARK 3 NUMBER OF REFLECTIONS : 51612 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : R FREE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6611 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 61 REMARK 3 SOLVENT ATOMS : 753 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.500 ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.000 ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : 1.500 ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.000 ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3AMV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-FEB-99. REMARK 100 THE DEPOSITION ID IS D_1000000514. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : JUL-97 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ELETTRA REMARK 200 BEAMLINE : 5.2R REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 180 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51612 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 13.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.9 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.08800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.3500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.24200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1 MM W1807 IN A MEDIUM CONSISTING OF REMARK 280 20-24 MG/ML ENZYME, 10 MM MAGNESIUM ACETATE, 3 MM DTT, 10 MM BES, REMARK 280 0.1 MM EDTA, AND 0.02% SODIUM AZIDE, PH 6.7 (22 DEG C). REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.90000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 63.60000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 63.60000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 86.85000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 63.60000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 63.60000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 28.95000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 63.60000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 63.60000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 86.85000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 63.60000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 63.60000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 28.95000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 57.90000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 10760 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 55880 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -36.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 115.80000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1 REMARK 465 ARG A 2 REMARK 465 PRO A 3 REMARK 465 LEU A 4 REMARK 465 ASP A 251 REMARK 465 PHE A 252 REMARK 465 ASN A 253 REMARK 465 LEU A 254 REMARK 465 LYS A 255 REMARK 465 ASP A 256 REMARK 465 PHE A 257 REMARK 465 ASN A 258 REMARK 465 VAL A 259 REMARK 465 LYS A 315 REMARK 465 PHE A 316 REMARK 465 GLY A 317 REMARK 465 CYS A 318 REMARK 465 ARG A 319 REMARK 465 ASP A 320 REMARK 465 PRO A 321 REMARK 465 VAL A 322 REMARK 465 ARG A 323 REMARK 465 THR A 324 REMARK 465 ALA A 836 REMARK 465 PRO A 837 REMARK 465 ASP A 838 REMARK 465 GLU A 839 REMARK 465 LYS A 840 REMARK 465 ILE A 841 REMARK 465 PRO A 842 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH2 ARG A 184 O HOH A 1089 2.07 REMARK 500 OE1 GLU A 26 O HOH A 1731 2.12 REMARK 500 O HOH A 1106 O HOH A 1157 2.17 REMARK 500 OE2 GLU A 207 O HOH A 1508 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 18 CA - CB - CG ANGL. DEV. = 17.2 DEGREES REMARK 500 LEU A 562 CA - CB - CG ANGL. DEV. = 14.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 6 -94.82 43.18 REMARK 500 ILE A 13 101.33 -58.39 REMARK 500 ARG A 16 -70.27 -4.24 REMARK 500 LEU A 18 -152.83 -106.88 REMARK 500 ALA A 19 26.69 -66.75 REMARK 500 GLU A 22 39.69 93.94 REMARK 500 LEU A 131 45.82 -86.67 REMARK 500 TYR A 203 -133.75 51.21 REMARK 500 PRO A 281 29.69 -78.19 REMARK 500 ASP A 339 -171.90 78.03 REMARK 500 ALA A 456 143.15 -171.97 REMARK 500 THR A 466 -97.63 -116.53 REMARK 500 LEU A 492 -73.28 -149.41 REMARK 500 ASP A 514 68.73 -166.80 REMARK 500 LYS A 568 164.54 175.45 REMARK 500 SER A 674 -69.06 -155.19 REMARK 500 SER A 751 67.63 -157.48 REMARK 500 LYS A 772 54.91 36.91 REMARK 500 REMARK 500 REMARK: NULL DBREF 3AMV A 1 842 UNP P00489 PHS2_RABIT 1 842 SEQADV 3AMV ALA A 609 UNP P00489 PRO 609 CONFLICT SEQRES 1 A 842 SER ARG PRO LEU SER ASP GLN GLU LYS ARG LYS GLN ILE SEQRES 2 A 842 SEP VAL ARG GLY LEU ALA GLY VAL GLU ASN VAL THR GLU SEQRES 3 A 842 LEU LYS LYS ASN PHE ASN ARG HIS LEU HIS PHE THR LEU SEQRES 4 A 842 VAL LYS ASP ARG ASN VAL ALA THR PRO ARG ASP TYR TYR SEQRES 5 A 842 PHE ALA LEU ALA HIS THR VAL ARG ASP HIS LEU VAL GLY SEQRES 6 A 842 ARG TRP ILE ARG THR GLN GLN HIS TYR TYR GLU LYS ASP SEQRES 7 A 842 PRO LYS ARG ILE TYR TYR LEU SER LEU GLU PHE TYR MET SEQRES 8 A 842 GLY ARG THR LEU GLN ASN THR MET VAL ASN LEU ALA LEU SEQRES 9 A 842 GLU ASN ALA CYS ASP GLU ALA THR TYR GLN LEU GLY LEU SEQRES 10 A 842 ASP MET GLU GLU LEU GLU GLU ILE GLU GLU ASP ALA GLY SEQRES 11 A 842 LEU GLY ASN GLY GLY LEU GLY ARG LEU ALA ALA CYS PHE SEQRES 12 A 842 LEU ASP SER MET ALA THR LEU GLY LEU ALA ALA TYR GLY SEQRES 13 A 842 TYR GLY ILE ARG TYR GLU PHE GLY ILE PHE ASN GLN LYS SEQRES 14 A 842 ILE CYS GLY GLY TRP GLN MET GLU GLU ALA ASP ASP TRP SEQRES 15 A 842 LEU ARG TYR GLY ASN PRO TRP GLU LYS ALA ARG PRO GLU SEQRES 16 A 842 PHE THR LEU PRO VAL HIS PHE TYR GLY ARG VAL GLU HIS SEQRES 17 A 842 THR SER GLN GLY ALA LYS TRP VAL ASP THR GLN VAL VAL SEQRES 18 A 842 LEU ALA MET PRO TYR ASP THR PRO VAL PRO GLY TYR ARG SEQRES 19 A 842 ASN ASN VAL VAL ASN THR MET ARG LEU TRP SER ALA LYS SEQRES 20 A 842 ALA PRO ASN ASP PHE ASN LEU LYS ASP PHE ASN VAL GLY SEQRES 21 A 842 GLY TYR ILE GLN ALA VAL LEU ASP ARG ASN LEU ALA GLU SEQRES 22 A 842 ASN ILE SER ARG VAL LEU TYR PRO ASN ASP ASN PHE PHE SEQRES 23 A 842 GLU GLY LYS GLU LEU ARG LEU LYS GLN GLU TYR PHE VAL SEQRES 24 A 842 VAL ALA ALA THR LEU GLN ASP ILE ILE ARG ARG PHE LYS SEQRES 25 A 842 SER SER LYS PHE GLY CYS ARG ASP PRO VAL ARG THR ASN SEQRES 26 A 842 PHE ASP ALA PHE PRO ASP LYS VAL ALA ILE GLN LEU ASN SEQRES 27 A 842 ASP THR HIS PRO SER LEU ALA ILE PRO GLU LEU MET ARG SEQRES 28 A 842 VAL LEU VAL ASP LEU GLU ARG LEU ASP TRP ASP LYS ALA SEQRES 29 A 842 TRP GLU VAL THR VAL LYS THR CYS ALA TYR THR ASN HIS SEQRES 30 A 842 THR VAL LEU PRO GLU ALA LEU GLU ARG TRP PRO VAL HIS SEQRES 31 A 842 LEU LEU GLU THR LEU LEU PRO ARG HIS LEU GLN ILE ILE SEQRES 32 A 842 TYR GLU ILE ASN GLN ARG PHE LEU ASN ARG VAL ALA ALA SEQRES 33 A 842 ALA PHE PRO GLY ASP VAL ASP ARG LEU ARG ARG MET SER SEQRES 34 A 842 LEU VAL GLU GLU GLY ALA VAL LYS ARG ILE ASN MET ALA SEQRES 35 A 842 HIS LEU CYS ILE ALA GLY SER HIS ALA VAL ASN GLY VAL SEQRES 36 A 842 ALA ARG ILE HIS SER GLU ILE LEU LYS LYS THR ILE PHE SEQRES 37 A 842 LYS ASP PHE TYR GLU LEU GLU PRO HIS LYS PHE GLN ASN SEQRES 38 A 842 LYS THR ASN GLY ILE THR PRO ARG ARG TRP LEU VAL LEU SEQRES 39 A 842 CYS ASN PRO GLY LEU ALA GLU ILE ILE ALA GLU ARG ILE SEQRES 40 A 842 GLY GLU GLU TYR ILE SER ASP LEU ASP GLN LEU ARG LYS SEQRES 41 A 842 LEU LEU SER TYR VAL ASP ASP GLU ALA PHE ILE ARG ASP SEQRES 42 A 842 VAL ALA LYS VAL LYS GLN GLU ASN LYS LEU LYS PHE ALA SEQRES 43 A 842 ALA TYR LEU GLU ARG GLU TYR LYS VAL HIS ILE ASN PRO SEQRES 44 A 842 ASN SER LEU PHE ASP VAL GLN VAL LYS ARG ILE HIS GLU SEQRES 45 A 842 TYR LYS ARG GLN LEU LEU ASN CYS LEU HIS VAL ILE THR SEQRES 46 A 842 LEU TYR ASN ARG ILE LYS LYS GLU PRO ASN LYS PHE VAL SEQRES 47 A 842 VAL PRO ARG THR VAL MET ILE GLY GLY LYS ALA ALA PRO SEQRES 48 A 842 GLY TYR HIS MET ALA LYS MET ILE ILE LYS LEU ILE THR SEQRES 49 A 842 ALA ILE GLY ASP VAL VAL ASN HIS ASP PRO VAL VAL GLY SEQRES 50 A 842 ASP ARG LEU ARG VAL ILE PHE LEU GLU ASN TYR ARG VAL SEQRES 51 A 842 SER LEU ALA GLU LYS VAL ILE PRO ALA ALA ASP LEU SER SEQRES 52 A 842 GLU GLN ILE SER THR ALA GLY THR GLU ALA SER GLY THR SEQRES 53 A 842 GLY ASN MET LYS PHE MET LEU ASN GLY ALA LEU THR ILE SEQRES 54 A 842 GLY THR MET ASP GLY ALA ASN VAL GLU MET ALA GLU GLU SEQRES 55 A 842 ALA GLY GLU GLU ASN PHE PHE ILE PHE GLY MET ARG VAL SEQRES 56 A 842 GLU ASP VAL ASP ARG LEU ASP GLN ARG GLY TYR ASN ALA SEQRES 57 A 842 GLN GLU TYR TYR ASP ARG ILE PRO GLU LEU ARG GLN ILE SEQRES 58 A 842 ILE GLU GLN LEU SER SER GLY PHE PHE SER PRO LYS GLN SEQRES 59 A 842 PRO ASP LEU PHE LYS ASP ILE VAL ASN MET LEU MET HIS SEQRES 60 A 842 HIS ASP ARG PHE LYS VAL PHE ALA ASP TYR GLU GLU TYR SEQRES 61 A 842 VAL LYS CYS GLN GLU ARG VAL SER ALA LEU TYR LYS ASN SEQRES 62 A 842 PRO ARG GLU TRP THR ARG MET VAL ILE ARG ASN ILE ALA SEQRES 63 A 842 THR SER GLY LYS PHE SER SER ASP ARG THR ILE ALA GLN SEQRES 64 A 842 TYR ALA ARG GLU ILE TRP GLY VAL GLU PRO SER ARG GLN SEQRES 65 A 842 ARG LEU PRO ALA PRO ASP GLU LYS ILE PRO MODRES 3AMV SEP A 14 SER PHOSPHOSERINE HET SEP A 14 10 HET GLC A 998 12 HET PLP A 999 15 HET BIN A 930 28 HET GOL A 996 6 HETNAM SEP PHOSPHOSERINE HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM PLP PYRIDOXAL-5'-PHOSPHATE HETNAM BIN 2,3-DICARBOXY-4-(2-CHLORO-PHENYL)-1-ETHYL-5- HETNAM 2 BIN ISOPROPOXYCARBONYL-6-METHYL-PYRIDINIUM HETNAM GOL GLYCEROL HETSYN SEP PHOSPHONOSERINE HETSYN PLP VITAMIN B6 PHOSPHATE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 SEP C3 H8 N O6 P FORMUL 2 GLC C6 H12 O6 FORMUL 3 PLP C8 H10 N O6 P FORMUL 4 BIN C20 H21 CL N O6 1+ FORMUL 5 GOL C3 H8 O3 FORMUL 6 HOH *753(H2 O) HELIX 1 1 VAL A 21 PHE A 37 1SEE REMARK 650 17 HELIX 2 2 PRO A 48 GLU A 76 1 29 HELIX 3 3 LEU A 95 LEU A 102 1 8 HELIX 4 4 GLU A 105 GLN A 114 1 10 HELIX 5 5 MET A 119 ILE A 125 1 7 HELIX 6 6 GLY A 135 THR A 149 1 15 HELIX 7 7 PRO A 194 PHE A 196 5 3 HELIX 8 8 TYR A 262 ARG A 269 1 8 HELIX 9 9 GLU A 273 SER A 276 5 4 HELIX 10 10 GLU A 290 LYS A 312 1 23 HELIX 11 11 PHE A 326 LYS A 332 5 7 HELIX 12 12 THR A 340 ASP A 355 5 16 HELIX 13 13 TRP A 361 THR A 371 1 11 HELIX 14 14 PRO A 381 ALA A 383 5 3 HELIX 15 15 VAL A 389 LEU A 395 1 7 HELIX 16 16 PRO A 397 ALA A 417 1 21 HELIX 17 17 VAL A 422 MET A 428 1 7 HELIX 18 18 MET A 441 GLY A 448 1 8 HELIX 19 19 ARG A 457 LYS A 465 1 9 HELIX 20 20 LYS A 469 LEU A 474 1 6 HELIX 21 21 PRO A 476 LYS A 478 5 3 HELIX 22 22 PRO A 488 TRP A 491 1 4 HELIX 23 23 PRO A 497 ILE A 507 1 11 HELIX 24 24 GLU A 510 ILE A 512 5 3 HELIX 25 25 LEU A 515 TYR A 524 5 10 HELIX 26 26 GLU A 528 GLU A 552 1 25 HELIX 27 27 GLN A 576 LYS A 592 1 17 HELIX 28 28 HIS A 614 HIS A 632 1 19 HELIX 29 29 VAL A 650 ALA A 659 1 10 HELIX 30 30 GLY A 677 ASN A 684 1 8 HELIX 31 31 GLY A 694 ALA A 703 5 10 HELIX 32 32 GLU A 705 ASN A 707 5 3 HELIX 33 33 VAL A 715 ARG A 724 1 10 HELIX 34 34 ALA A 728 ARG A 734 5 7 HELIX 35 35 PRO A 736 SER A 747 1 12 HELIX 36 36 PRO A 755 HIS A 767 5 13 HELIX 37 37 VAL A 773 LYS A 792 5 20 HELIX 38 38 PRO A 794 THR A 807 1 14 HELIX 39 39 GLY A 809 PHE A 811 5 3 HELIX 40 40 SER A 813 GLU A 823 1 11 SHEET 1 A 7 GLU A 190 ARG A 193 0 SHEET 2 A 7 VAL A 221 PRO A 231 -1 N ASP A 227 O LYS A 191 SHEET 3 A 7 VAL A 238 ALA A 248 -1 N LYS A 247 O LEU A 222 SHEET 4 A 7 ALA A 154 ILE A 159 1 N GLY A 156 O THR A 240 SHEET 5 A 7 ARG A 81 LEU A 85 1 N ILE A 82 O TYR A 155 SHEET 6 A 7 VAL A 333 ASN A 338 1 N ALA A 334 O ARG A 81 SHEET 7 A 7 CYS A 372 THR A 375 1 N ALA A 373 O ILE A 335 SHEET 1 B 2 ASN A 167 CYS A 171 0 SHEET 2 B 2 TRP A 174 GLU A 178 -1 N GLU A 178 O ASN A 167 SHEET 1 C 2 LEU A 198 PHE A 202 0 SHEET 2 C 2 GLN A 219 ALA A 223 -1 N ALA A 223 O LEU A 198 SHEET 1 D 2 ARG A 205 HIS A 208 0 SHEET 2 D 2 ALA A 213 VAL A 216 -1 N VAL A 216 O ARG A 205 SHEET 1 E 2 ARG A 386 PRO A 388 0 SHEET 2 E 2 ARG A 438 ASN A 440 -1 N ILE A 439 O TRP A 387 SHEET 1 F 2 VAL A 452 GLY A 454 0 SHEET 2 F 2 PHE A 479 ASN A 481 1 N GLN A 480 O VAL A 452 SHEET 1 G 3 LEU A 562 VAL A 567 0 SHEET 2 G 3 ARG A 601 GLY A 606 1 N THR A 602 O LEU A 562 SHEET 3 G 3 LEU A 640 PHE A 644 1 N ARG A 641 O ARG A 601 SHEET 1 H 2 LEU A 662 GLN A 665 0 SHEET 2 H 2 LEU A 687 GLY A 690 1 N LEU A 687 O SER A 663 LINK NZ LYS A 680 C4A PLP A 999 1555 1555 1.36 CRYST1 127.200 127.200 115.800 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007862 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007862 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008636 0.00000